Take a virtual tour of the fully automated AUTOSTEM pipeline

Take the virtual tour here: The AUTOSTEM platform concept was designed as a user-oriented, closed, automated system to provide an efficient pipeline for the delivery of large numbers of therapeutic cells (mesenchymal stromal cells or MSCs). The process starts with a bone marrow donation, taken from the hip bone of a donor using a novel[…]

Fraunhofer IPT Press Release: “Fully equipped, automated laboratory advances for clinical stem cell therapies”

Read the entire Fraunhofer IPT press release issued 12 February 2019 here. Below is an excerpt from it. Exploring commercial perspectives of the project outputs The AUTOSTEM team which has been working together in the project represents a wealth of experience in regenerative medicine, automation and robotics, bio-reactors and cell production, regulatory affairs and quality[…]

Final AUTOSTEM plenary meeting, Aachen, Germany

The final AUTOSTEM meeting was hosted by Fraunhofer-IPT in Aachen, Germany. The two-day meeting was held December 11 and 12, 2018 and 32 partner representatives were present. Coordinator Mary Murphy (NUIG) welcomed, greeted and opened the meeting. Nora Ward (PT) reviewed the reporting requirements that are outstanding, the budgetary figures, deliverables achieved, milestones, scheduling, risk[…]

Aston U’s Christopher Hewitt will present AUTOSTEM findings at Scale-up and Manufacturing conference, U.S.

The AUTOSTEM team at Aston University, Birmingham, U.K.  have had an abstract accepted and been selected for a poster presentation at the ECI Scale-up and Manufacturing of Cell-based Therapies VI in San Diego, California, the U.S. The conference will take place the 15-19 January 2019. The title of the accepted abstract is “Isolation and expansion of human[…]